Evaluation of Primary Congenital Glaucoma at Asyut University Hospital

Primary Congenital Glaucoma Clinical Trial

Official title:

Evaluation of Primary Congenital Glaucoma Management at Asyut University Hospital

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05205122
• Other study ID #: Congenital glaucoma
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 1, 2022
• Est. completion date: January 1, 2023

Study information

• Verified date: January 2022
• Source: Assiut University
• Contact: Omar Abdelkarem Hasan, M.B.B.Ch.
• Phone: 00201000525341
• Email: oabdelkarem[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of the management of primary congenital glaucoma regarding the results of surgical intervention at Asyut University Hospital

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: January 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 3 Years

Eligibility

Inclusion Criteria:

Typical symptoms of epiphora , photophobia and blepharospasm Corneal diameter > 13 mm Increased ocular tension > 25 mmHg UGA using schiotz tonometer Exclusion Criteria: Infants with history of previous surgery Secondary glaucoma Glaucoma associated with other congenital anomalies

Related Conditions & MeSH terms

• Glaucoma
• Primary Congenital Glaucoma

Intervention

Procedure:
• Combined trabeculotomy-trabeculectomy with mitomycin C
Combined trabeculotomy-trabeculectomy with mitomycin C Will be done in all cases

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Omar Abdelkarem Hasan

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IOP follow up	postoperative measurment of Intra ocular pressure by shoitz tonometer	1 year